
Unigra 50mg Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Sildenafil (50mg)
Overview Unigra 50mg Tablet
For men experiencing erectile dysfunction, the prescription medication Unigra 50mg Tablet enhances penile blood flow, facilitating erection achievement and maintenance. Classified as a phosphodiesterase-5 (PDE5) inhibitor, it can be taken with or without food, ideally an hour before anticipated sexual activity. Individual response varies, but the effect typically manifests within 30-60 minutes, contingent upon sexual stimulation. This medication is solely for erectile dysfunction and should not be used otherwise. Exceeding one tablet daily is inadvisable. Common side effects include facial flushing, headache, dizziness, visual blurring, myalgia, gastrointestinal upset, and skin rash. Persistent or bothersome side effects warrant medical consultation, potentially necessitating dosage adjustment or alternative treatment. Unigra 50mg Tablets are not for women. Concurrent use of other impotence medications or nitrates (often prescribed for angina) requires prior physician approval. Individuals with severe heart or liver disease, recent stroke or myocardial infarction, or hypotension should avoid this medication. Pre-existing health conditions must be disclosed to your doctor. Dizziness necessitates abstaining from driving. Alcohol consumption should be minimized due to increased side effect risk.
Uses of Unigra 50mg Tablet
Managing Erectile Dysfunction
Major Benefits of Unigra 50mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Unigra 50mg Tablets can be administered with or without food, although consistent timing is recommended.
Common Side effects of Unigra 50mg Tablet:
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Headache
- Blurred vision
- Indigestion
- Muscle pain
- Upset stomach
- Rash
- Nasal congestion (stuffy nose)
- Dizziness
- Nausea
How to use Unigra 50mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Unigra 50mg Tablets can be consumed with or without food, however, consistent timing is recommended.
How Unigra 50mg Tablet works:
Unigra 50mg tablets contain a PDE-5 inhibitor that promotes penile blood vessel dilation. Increased blood flow, triggered by sexual stimulation, facilitates the attainment and maintenance of an erection sufficient for intercourse.
SAFETY ADVICE
AlcoholUNSAFE
Combining Unigra 50mg Tablet and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Data on Unigra 50mg Tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Unigra 50mg Tablet use while breastfeeding is lacking. Seek medical advice. This medication is not intended for use in women.
DrivingUNSAFE
Taking a 50mg Unigra tablet might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Unigra 50mg tablets pose no known safety risk for patients with kidney impairment; dose alteration is typically unnecessary. Nevertheless, disclosure of pre-existing kidney conditions to your physician is advisable. Dose reduction might be explored if the medication proves poorly tolerated.
LiverCAUTION
Patients with severe hepatic impairment should use Unigra 50mg Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised, as data regarding Unigra 50mg Tablet use in this patient population is scarce.
What if you forget to take Unigra 50mg Tablet :
Should you forget a Unigra 50mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Unigra 50mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Benzenesulfonamide derivative |
| Developing Habits | No. |
| Treatment Category | Enhancements for Intimate Wellness |
| Action Class | PDE5 inhibitors |
